2 Ex-Dividend Stocks With Buy Ratings
Both stocks were rated buy at TheStreet Ratings.
The health care benefits company is scheduled to report its first-quarter earnings on April 26. Analysts, on average, anticipate earnings of $1.39 a share on revenue of $8.69 billion.
"For Aetna, our downgrade primarily reflects its more limited growth prospects in the commercial health plan business," Goldman Sachs analysts wrote in a March 22 report. "Since adding Aetna to the Americas Buy List on February 7, 2011, the stock is up 26% (vs. S&P 500 +6%)."
Forward Annual Dividend Yield: 1.4%
Rated "A+ (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin increased from the previous year.
Aetna has weak liquidity. Its Quick Ratio is 0.55, which demonstrates a lack of ability to meet its short-term cash needs.
In the fourth quarter, stockholders' net worth increased 2.31% from the prior year.